Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study

Affiliations

• ¹ Division of Mental Health and Addiction, Vestfold, Hospital Trust, Postboks 2168, 3103 Tonsberg, Norway. Electronic address: Therese.Torgersen@siv.no.
• ² Division of Mental Health and Addiction, Vestfold, Hospital Trust, Postboks 2168, 3103 Tonsberg, Norway.
• ³ Division of Mental Health and Addiction, Vestfold, Hospital Trust, Postboks 2168, 3103 Tonsberg, Norway; Department of Psychology, University of Oslo, P.O box 1094, Blindern, 0317 Oslo, Norway.
• ⁴ Faculty of Humanities, Sports and Educational Science, University College of South-Eastern Norway, Post office box 235, 3603 Kongsberg, Norway.
• ⁵ NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Psychosis Research Unit/TOP, Ullevaal Hospital, Building 49, P.O Box 4956 Nydalen, 0424 Oslo, Norway.
• ⁶ Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Pb 4950 Nydalen, 0424 Oslo, Norway.
• ⁷ Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, P.O Box 1072, Blindern, 0316 Oslo, Norway.
• ⁸ Mental Health Centre Glostrup, Copenhagen University Hospital, Kristineberg 3, 2100 Copenhagen O, Denmark.
• ⁹ Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Postboks 4950 Nydalen, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo Faculty of Health Sciences, P.O box 1171, Blindern, 0318 Oslo, Norway; K.G. Jebsen TREC, University of Tromso, 9037 Tromso, Norway.
• ¹⁰ Division of Mental Health and Addiction, Vestfold, Hospital Trust, Postboks 2168, 3103 Tonsberg, Norway; Mental Health Centre Glostrup, Copenhagen University Hospital, Kristineberg 3, 2100 Copenhagen O, Denmark.